GJMic.070105

Guidelines

Chinese Guidelines on Standardized Technical Specifications for Laboratory Preparation and Quality Control of Fecal Microbiota Transplantation (2026 Edition)

 

Zhi Guo1,2,*,#, Li Zhang2,#, Zihan Chen2,#, Xiaochen Xiang2,#, Xiaoan Li3, Xiaobo Wang4, Xiaojun Xu4, Jun Wang5, Yi Hao6, Hua Ren7, Jing Liang8, Hao Zhou9, Mingqiang Qiao10, Feng Chen11, Yukui Zhang12, Bichuan Hu13, Ziming Huang14, Min Tang15, Qian Yin16, Guoliang Pi17, Yanli Zhu18, Jingye Meng19, Rong Shu20, Peng Chen21, Hongyan Zhang22, Rong Qu23, Yu J. Cao24, Liang Wang25, Hui Long26, Zhong Chen27, Tieying Hou27, Xiaohua Tan28, Liqiong Liu1, Danyu Wang1, Mingxin He1, Qingming Wu2, Qiang Wang2,*and the Tumor and Microecology Professional Committee of the Chinese Anti-Cancer Association1,*

1Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen 518052, China. 2Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China. 3NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital), Mianyang 621000, China. 4Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China. 5Department of Hematology, Hongkong University Shenzhen Hospital, Shenzhen 518048, China. 6Shenzhen Xbiome Biotech Co., Ltd, Shenzhen 518038, China. 7School of Medicine, Southern University of Science & Technology, Shenzhen 518055, China. 8Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan 250014, China. 9Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. 10College of Life Sciences, Nankai University, Tianjin 300071, China. 11The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China. 12Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang 441000, China. 13Xiangyang Hospital of Integrated Traditional Chinese and Western Medicine, Xiangyang 441004, China. 14Hubei Maternal and Child Health Care Hospital, Wuhan 430070, China. 15Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China. 16Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. 17Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical, Wuhan 430079, China. 18The First Affiliated Hospital of Henan Medical University, Xinxiang 453100, China. 19National Clinical Research Centre for Infectious Diseases, The Third People’s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China. 20Department of Anesthesiology, the Third People’s Hospital of Hubei Province, Wuhan 430033, China. 21Department of Hematology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing 100700, China. 22Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China. 23Huizhou Central People’s Hospital, Huizhou 516001, China. 24State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055‌, China. 25Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China. 26Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430010, China. 27Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen 518052, China. 28Department of Oncology, Qingdao Eighth People’s Hospital, Shandong Second Medical University, Qingdao, China.

#, Authors contributed equally.
*, Correspondence
Professor Zhi Guo, PhD, Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen 518052, China. E-mail: guozhi77@126.com. 
Professor Qiang Wang, PhD, Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key November 12Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China. E-mail: wangqiang@wust.edu.cn.
Received: May 29, 2026; Accepted: August 28, 2026; Published online: November 12, 2026.
Cite this paper: Zhi Guo, Li Zhang, Zihan Chen, Xiaochen Xiang, Xiaoan Li, Xiaobo Wang, Xiaojun Xu, Jun Wang, Yi Hao, Hua Ren, Jing Liang, Hao Zhou, Mingqiang Qiao, Feng Chen, Yukui Zhang, Bichuan Hu, Ziming Huang, Min Tang, Qian Yin, Guoliang Pi, Yanli Zhu, Jingye Meng, Rong Shu, Peng Chen, Hongyan Zhang, Rong Qu, Yu J. Cao, Liang Wang, Hui Long, Zhong Chen, Tieying Hou, Xiaohua Tan, Liqiong Liu, Danyu Wang, Mingxin He, Qingming Wu, Qiang Wang, and the Tumor and Microecology Professional Committee of the Chinese Anti-Cancer Association. Chinese guidelines on standardized technical specifications for laboratory preparation and quality control of fecal microbiota transplantation (2026 Edition). Global Journal of Microbiology, 2026;7(1):24-37. http://naturescholars.com/gjmic.070105. https://doi.org/10.46633/gjmic.070105.
Copyright © 2026 by Scholars Publishing, LLC.

Abstract

Fecal microbiota transplantation (FMT) has been attempted as an emerging therapeutic tool for a variety of diseases. FMT is an effective method to rebuild intestinal microecology, which refers to transplanting functional flora from healthy human feces into the patient’s intestine after treatment to rebuild new intestinal flora and restore the diversity and biological of intestinal flora, so as to realize the treatment of diseases inside and outside the intestinal tract and achieve the purpose of curing diseases. In the field of basic and clinical research targeting FMT, there is a need to recognize and understand the laboratory assays for FMT preparation and quality control. Since there is no unified standard for the experimental procedure and quality management of FMT technology, in order to clarify the standardized laboratory technical specifications for FMT preparation and quality control, the Tumor and Microecology Professional Committee of the Chinese Anti-Cancer Association and the Chinese Infection Immunology and Microecology Research Translation Collaborative Group organized relevant experts to discuss and propose the “Chinese guidelines on standardized technical specifications for laboratory preparation and quality control of fecal microbiota transplantation (2026 Edition)”, which provides a basis for further application and in-depth research in the basic and clinical fields of FMT.

Keywords

Fecal microbiota transplantation; gut microecology; experimental procedures; quality control; technical specifications; guidelines.